Rock Creek Pharmaceuticals Inc  

(Public, NASDAQ:RCPI)   Watch this stock  
Find more results for NASDAQ:STSI
-0.008 (-7.27%)
Mar 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.10 - 0.11
52 week 0.09 - 0.86
Open 0.10
Vol / Avg. 538,511.00/1.20M
Mkt cap 22.19M
P/E     -
Div/yield     -
EPS -0.18
Shares 201.73M
Beta 2.61
Inst. own 18%
Jan 12, 2015
Rock Creek Pharmaceuticals Inc at EBD Biotech Showcase
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -291.27% -333.34%
Return on average equity - -
Employees 10 -
CDP Score - -


2040 Whitfield Avenue, Suite 300
United States - Map
+1-804-5271970 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Rock Creek Pharmaceuticals, Inc. is a pharmaceutical company. The Company is specifically focused on research, development, and commercialization of compounds and formulations targeting inflammatory and neurological disorders. The Company is engage in and advance research and clinical development of pharmaceuticals to provide therapeutic solutions. The Company is engaged in vitro and in vivo ability to modulate the expression of specific inflammatory molecules considered relevant to many chronic inflammatory disease states. The Company has conducted in vitro and in vivo toxicological and pharmacological research on lead drug candidates, and poised to begin first Phase 1 clinical trials. The Company´┐Żs research area targets are Osteoarthritis, Ulcerative Colitis, Psoriasis, Smoking Cessation, and Hashimoto's Thyroiditis.

Officers and directors

Michael John Mullan Ph.D., M.D. Chairman of the Board, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Christopher C. Chapman M.D., Jr. President, Director
Age: 62
Bio & Compensation  - Reuters
Benjamin M. Dent Chief Financial Officer, Vice President - Operations, Treasurer, Secretary
Age: 63
Bio & Compensation  - Reuters
Lee M. Canaan Independent Director
Age: 58
Bio & Compensation  - Reuters
Edward J. McDonnell Independent Director
Age: 69
Bio & Compensation  - Reuters
Scott P. Sensenbrenner Independent Director
Age: 45
Bio & Compensation  - Reuters